This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0367U only for Oncuria® Predict from DiaCarta Clinical Lab, DiaCarta Inc. Using immunoassay technique, the test evaluates a urine specimen for the levels of 10 protein biomarkers listed in the code and performs an algorithmic analysis to report a risk score for the likelihood that the patient will experience rapid recurrence of recurrent or persistent cancer following transurethral resection or biopsy of a bladder cancer tumor.
For clinical responsibility, terminology, tips and additional info
start codify free trial.